Evaluate the perspectives of cancer survivor patients and caregivers on using an intrathecal drug delivery system as a continuum of pain management care using a qualitative study.


Targeted medication delivery near the spinal cord (intrathecal pump) may be offered for cancer pain treatment in carefully selected patients. Prior studies showed an improved functional status reduction in oral medications and their side effects. Cancer survivors receiving intrathecal pump treatment for pain are eligible to participate in the research and share their stories. After consenting, a interview (45 minutes by zoom) will be conducted before and after the treatment to improve our understanding of patient perceptions of pain treatment with an intrathecal pump.

I'm interested

Male or Female
18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• cancer survivors with pain for more than 3 months duration who may benefit from intrathecal pump treatment for pain
Exclusion Criteria:

• people who are not eligible for treatment with an intrathecal pump


Cancer Pain, Cancer Survivor, Intrathecal drug delivery systems (IDDS), Palliative Care, Chronic Pai

Candace Nelson -
Vasudha Goel